135 related articles for article (PubMed ID: 15002926)
1. Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama.
Barton EH; Barton JC; Hollowell WW; Acton RT
Ethn Dis; 2004; 14(1):73-81. PubMed ID: 15002926
[TBL] [Abstract][Full Text] [Related]
2. Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama.
Acton RT; Barton EH; Hollowell WW; Dreibelbis AL; Go RC; Barton JC
BMC Cancer; 2004 Aug; 4():47. PubMed ID: 15310399
[TBL] [Abstract][Full Text] [Related]
3. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton EH; Acton RT
BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
[TBL] [Abstract][Full Text] [Related]
4. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y.
Barton JC; Bertoli LF; Acton RT
Blood Cells Mol Dis; 2003; 31(1):102-11. PubMed ID: 12850493
[TBL] [Abstract][Full Text] [Related]
5. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload.
Barton EH; West PA; Rivers CA; Barton JC; Acton RT
Blood Cells Mol Dis; 2001; 27(1):279-84. PubMed ID: 11358388
[TBL] [Abstract][Full Text] [Related]
6. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
7. HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama.
Barton JC; Acton RT
BMC Med Genet; 2002 Oct; 3():9. PubMed ID: 12370085
[TBL] [Abstract][Full Text] [Related]
8. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands.
Barton JC; Sawada-Hirai R; Rothenberg BE; Acton RT
Blood Cells Mol Dis; 1999; 25(3-4):147-55. PubMed ID: 10575540
[TBL] [Abstract][Full Text] [Related]
9. Diabetes in first-degree family members: a predictor of type 2 diabetes in 159 nonscreening Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton JC; Acton RT
Diabetes Care; 2014; 37(1):259-66. PubMed ID: 23990522
[TBL] [Abstract][Full Text] [Related]
10. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population.
Barton JC; Rivers CA; Niyongere S; Bohannon SB; Acton RT
BMC Med Genet; 2004 Dec; 5():29. PubMed ID: 15610558
[TBL] [Abstract][Full Text] [Related]
11. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: predictions from a model based on national, racial, and ethnic group composition in central Alabama.
Barton JC; Acton RT
Genet Test; 2000; 4(2):199-206. PubMed ID: 10953960
[TBL] [Abstract][Full Text] [Related]
12. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
Acton RT; Barton JC; Snively BM; McLaren CE; Adams PC; Harris EL; Speechley MR; McLaren GD; Dawkins FW; Leiendecker-Foster C; Holup JL; Balasubramanyam A;
Ethn Dis; 2006; 16(4):815-21. PubMed ID: 17061732
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
14. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study.
Barton JC; Acton RT; Lovato L; Speechley MR; McLaren CE; Harris EL; Reboussin DM; Adams PC; Dawkins FW; Gordeuk VR; Walker AP;
Clin Genet; 2006 Jan; 69(1):48-57. PubMed ID: 16451136
[TBL] [Abstract][Full Text] [Related]
15. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology.
Hanson EH; Imperatore G; Burke W
Am J Epidemiol; 2001 Aug; 154(3):193-206. PubMed ID: 11479183
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 6p SNP microhaplotypes and IgG3 levels in hemochromatosis probands with HFE p.C282Y homozygosity.
Barton JC; Barton JC; Cruz E; Teles MJ; Guimarães JT; Porto G
Blood Cells Mol Dis; 2020 Nov; 85():102461. PubMed ID: 32623342
[TBL] [Abstract][Full Text] [Related]
17. Celtic origin of the C282Y mutation of hemochromatosis.
Lucotte G; Mercier G
Genet Test; 2000; 4(2):163-9. PubMed ID: 10953956
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.
Waalen J; Felitti V; Gelbart T; Ho NJ; Beutler E
Mayo Clin Proc; 2002 Jun; 77(6):522-30. PubMed ID: 12059121
[TBL] [Abstract][Full Text] [Related]
19. Significance of H63D homozygosity in a Basque population with hemochromatosis.
Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes.
Barton JC; Barton JC; Adams PC
Ann Hepatol; 2019; 18(2):354-359. PubMed ID: 31056361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
